Transcription Activation by Nuclear Receptors

References

• Gronemeyer H., Meyer M. E., Bocquel M. T., Kastner P., Turcotte B., Chambon P. Progestin receptors: Isoforms and antihormone action. J. Steroid Biochem. Molec. Biol. 1991; 40: 271–278
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D. J., Ong E. S., Dyck J. A., Evans R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224–229
   PubMed Web of Science ®Google Scholar
• Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J. Y., Staub A., Garnier J. M., Mader S., Chambon P. Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to efficiently bind target sequences. Cell 1992; 68: 377–395
   PubMed Web of Science ®Google Scholar
• Heyman R. A., Mangelsdorf D. J., Cyck J. A., Stein R. B., Eichele G., Evans R. M., Thaller C. 9–cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397–406
   PubMed Web of Science ®Google Scholar
• Levin A. A., Sturzenbecker L. J., Kazmer S., Busakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo J. F. The 9–cis stereoisomer of retinoic acid binds and activates the nuclear receptor RXRalpha. Nature 1992; 355: 359–361
   PubMed Web of Science ®Google Scholar
• Ylikomi T., Bocquel M. T., Berry M., Gronemeyer H., Chambon P. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. 1992, submitted
   Google Scholar
• Beato M. Gene regulation by steroid hormones. Cell 1989; 56: 335–344
   PubMed Web of Science ®Google Scholar
• Evans R. M. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889–895
   PubMed Web of Science ®Google Scholar
• Green S., Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 1988; 4: 309–314
   PubMed Web of Science ®Google Scholar
• Gronemeyer H. Transcription activation by estrogen and progesterone receptors. Ann. Rev. Genet. 1991; 25: 89–123
   PubMed Web of Science ®Google Scholar
• Beato M. Transcriptional control by nuclear receptors. FASEB J. 1991; 5: 2044–2051
   PubMed Web of Science ®Google Scholar
• Wahli W., Martinez E. Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J. 1991; 5: 2243–2249
   PubMed Web of Science ®Google Scholar
• Forman B. M., Samuels H. H. Interactions among a subfamily of nuclear hormone receptors: The regulatory zipper model. Mol. Endocrinol. 1990; 4: 1293–1301
   PubMedGoogle Scholar
• Hager G. L., Archer T. K. Nuclear Hormone Receptors, M. G. Parker. Academic Press, London 1991; 217–234
   Google Scholar
• Klein-Hitpass L., Ryffel G. U., Heitlinger E., Cato A. C. B. A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucl. Acids Res. 1988; 16: 647–663
   PubMed Web of Science ®Google Scholar
• Martinez A., Givel F., Wahli W. The estrogen-responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid responsive element. EMBO J. 1987; 6: 3719–3727
   PubMed Web of Science ®Google Scholar
• Klein-Hitpass L., Schorpp M., Wagner U., Ryffel G. U. An estrogen-responsive element derived from the 5′flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 1986; 46: 1053–1061
   PubMed Web of Science ®Google Scholar
• Klock G., Straehle U., Schütz B. Oestrogen and glucocorticoid responsive elements are closely related but distinct. Nature 1987; 329: 734–735
   PubMed Web of Science ®Google Scholar
• Nordeen S. K., Suh B. J., Kuhnel B., Hutchinson C. A., III. Structural determinants of a glucocorticoid receptor recognition element. Mol. Endocrinol. 1990; 4: 1866–1873
   PubMedGoogle Scholar
• Mader S., Kumar V., de Verneuil H., Chambon P. Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 1989; 338: 271–274
   PubMed Web of Science ®Google Scholar
• Umesono K., Evans R. M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989; 57: 1139–1146
   PubMed Web of Science ®Google Scholar
• Danielsen M., Hinck L., Ringold G. M. Two amino acids within the knuckle of the first zinc finger specific DNA response element activation by the glucocorticoid receptor. Cell 1989; 57: 1131–1138
   PubMed Web of Science ®Google Scholar
• Härd T., Kellenbach E., Boelens R., Kapstein R., Dahlman K., Carlstedt-Duke J., Freedman L. P., Maler B. A., Hyde E. I., Gustafsson J. A., Yamamoto K. R. 1HNMR studies of the glucocorticoid receptor DNA-binding domain sequential assignments and identification of secondary structure elements. Biochemistry 1990; 29: 9015–9023
   PubMed Web of Science ®Google Scholar
• Schwabe J. W. R., Neuhaus D. D., Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 1990; 348: 458–461
   PubMed Web of Science ®Google Scholar
• Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R., Sigler P. B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991; 352: 497–505
   PubMed Web of Science ®Google Scholar
• Ham J., Thompson A., Needham M., Webb P., Parker M. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucl. Acids Res. 1988; 16: 5263–5276
   PubMed Web of Science ®Google Scholar
• Shemshedini L., Knauthe R., Sassone-Corsi P., Pornon A., Gronemeyer H. Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J. 1991; 12: 3839–3849
   Google Scholar
• Arriza J. L., Weinberger C., Cerelli G., Glaser T. M., Handelin B. L., Housman D. E., Evans R. M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987; 237: 268–275
   PubMed Web of Science ®Google Scholar
• Glass C. K., Holloway J. M., Devary O. V., Rosenfeld M. G. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 1988; 54: 313–323
   PubMed Web of Science ®Google Scholar
• Umesono K., Murakami K. K., Thompson C. C., Evans R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991; 65: 1255–1266
   PubMed Web of Science ®Google Scholar
• Näär A. M., Boutin J. M., Lipkin S. M., Yu V. C., Holloway J. M., Glass C. K., Rosenfeld M. G. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 1991; 65: 1276–1279
   Web of Science ®Google Scholar
• Mangelsdorf D. J., Umesono K., Kliewer S. A., Borgmeyer U., Ong E. S., Evans R. M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 1991; 66: 555–561
   PubMed Web of Science ®Google Scholar
• Smith W. C., Nakshatri H., Leroy P., Rees J., Chambon P. A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. EMBO J. 1991; 10: 2223–2230
   PubMed Web of Science ®Google Scholar
• de Verneuil H., Metzger D. The lack of the transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein. Nucl. Acids Res. 1990; 18: 4489–4497
   PubMed Web of Science ®Google Scholar
• Yu V. C., Delsert C., Andersen B., Holloway J. M., Devary O. V., Näär A. M., Kim S. Y., Boutin J. M., Glass C. K., Rosenfeld M. G. RXRB: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1992; 67: 1251–1266
   Web of Science ®Google Scholar
• Meyer M. E., Pornon A., Ji J., Bocquel M. T., Chambon P., Gronemeyer H. Agonistic and antagonistic activities or RU486 on the functions of the human progesterone receptor. EMBO J. 1990; 12: 3923–3932
   Google Scholar
• Gronemeyer H., Turcotte B., Quirin-Stricker C., Bocquel M. T., Meyer M. E., Krozowski Z., Jeltsch J. M., Lerouge T., Garnier J. M., Chambon P. The chicken progesterone receptor: sequence, expression and functional analysis. EMBO J. 1987; 6: 3985–3994
   PubMed Web of Science ®Google Scholar
• Shemshedini L., Ji J., Brou C., Chambon P., Gronemeyer H. In vitro activity of the transcription activation functions of the progesterone receptor. J. Biol. Chem. 1992; 267: 1834–1839
   PubMed Web of Science ®Google Scholar
• Webster N. J. G., Green S., Jin J. R., Chambon P. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 1988; 54: 199–207
   PubMed Web of Science ®Google Scholar
• Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989; 59: 477–487
   PubMed Web of Science ®Google Scholar
• Kumar V., Green S., Stack G., Berry M., Jin J. R., Chambon P. Functional domains of the human estrogen receptor. Cell 1987; 51: 941–951
   PubMed Web of Science ®Google Scholar
• Godowski P. J., Rusconi S., Miesfeld R., Yamamoto K. R. Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature 1987; 325: 365–368
   PubMed Web of Science ®Google Scholar
• Hollenberg S. M., Evans R. M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 1988; 55: 899–906
   PubMed Web of Science ®Google Scholar
• Webster N. J. G., Green S., Tasset D., Ponglikitmongkol M., Chambon P. The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon. EMBO J. 1989; 8: 1441–1446
   PubMed Web of Science ®Google Scholar
• Berry M., Metzger D., Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4–hydroxytamoxifen. EMBO J. 1990; 9: 2811–2818
   PubMed Web of Science ®Google Scholar
• Bocquel M. T., Kumar V., Stricker C., Chambon P., Gronemeyer H. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucl. Acids Res. 1989; 17: 2581–2595
   PubMed Web of Science ®Google Scholar
• Martinez E., Wahli W. Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity. EMBO J. 1989; 8: 3781–3791
   PubMed Web of Science ®Google Scholar
• Schmid W., Straehle U., Schütz G., Schmitt J., Stunnenberg H. Glucocorticoid receptor binds cooperatively to adjacent recognition sites. EMBO J. 1989; 8: 2257–2263
   PubMed Web of Science ®Google Scholar
• Tasset D., Tora L., Fromental C., Scheer E., Chambon P. Distinct classes of transcriptional activating domains function by different mechanisms. Cell 1990; 62: 1177–1187
   PubMed Web of Science ®Google Scholar
• Meyer M. E., Quirin-Stricker C., Lerouge T., Bocquel M. T., Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 1992; 267, in press
   Web of Science ®Google Scholar
• Meyer M. E., Gronemeyer H., Turcotte B., Bocquel M. T., Tasset D., Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 1989; 57: 433–442
   PubMed Web of Science ®Google Scholar
• Gill G., Ptashne M. Negative effect of the transcriptional activator GAL4. Nature 1988; 334: 721–724
   PubMed Web of Science ®Google Scholar
• Baulieu E. E. Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science 1989; 245: 1351–1357
   PubMed Web of Science ®Google Scholar
• Renoir J. M., Radanyi C., Faber L., Baulieu E. E. The non-DNA-binding heterooligomeric form of mammalian steroid hormone receptors contains a hsp90–bound 59–kilodalton protein. J. Biol. Chem. 1990; 265: 10740–10745
   PubMed Web of Science ®Google Scholar
• Ullmann A., Teutsch G., Philibert D. RU486. Scientific American 1990; 262: 18–24
   PubMedGoogle Scholar
• Moguilewski M., Philibert D. The Antiprogestin Steroid RU486 and Human Fertility Control, E. E. Baulieu, S. J. Segal. Plenum, New York, 87–98
   Google Scholar
• Teutsch G. The Antiprogestin Steroid RU486 and Human Fertility Control, E. E. Baulieu, S. J. Segal. Plenum, New York, 27–47
   Google Scholar
• Wakeling A. E., Bowler J. Biology and mode of action of pure antiestrogens. J. Steroid Biochem. 1988; 30: 141–147
   PubMedGoogle Scholar
• Fawell S. E., White R., Hoare S., Sydenham M., Page M., Parker M. G. Inhibition of estrogen receptor-DNA binding by the “pure” antiestrogen ICI 164 384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA 1990; 87: 6883–6887
   PubMed Web of Science ®Google Scholar
• Fawell S. E., Lees J. A., White R., Parker M. G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 1990; 60: 953–962
   PubMed Web of Science ®Google Scholar
• Sabbah M., Gouilleux F., Sola B., Redeuilh G., Baulieu E. E. Structural differences between the hormone and antihormone estrogen receptor complexes bound to the hormone response element. Proc. Natl. Acad. Sci. USA 1991; 88: 390–394
   PubMed Web of Science ®Google Scholar
• Metzger D., Berry M., Chambon P. 1992, in preparation
   Google Scholar
• Pham T. A., Elliston J. F., Nawaz Z., McDonnell D. P., Tsai M. J., O'Malley B. W. Antiestrogen can establish nonproductive complexes and alter chromatin structure at target enhancers. Proc. Natl. Acad. Sci. USA 1991; 88: 3125–3129
   PubMed Web of Science ®Google Scholar
• Benhamou B., Garcia T., Lerouge T., Vergezac A., Gofflo D., Bigogne C., Chambon P., Gronemeyer H. A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 1992; 255: 206–209
   PubMed Web of Science ®Google Scholar
• Klein-Hitpass L., Cato A. C. B., Henderson D., Ryffel G. U. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucl. Acids Res. 1991; 19: 1227–1234
   PubMed Web of Science ®Google Scholar
• Bocquel M. T., Ji J., Ylikomi T., Benhamou B., Vergezac A., Chambon P., Gronemeyer H. Type II antagonists impair DNA binding of steroid hormone receptors. 1992, submitted
   Google Scholar
• Moudgil V. K., Nath R., Bhakta A., Nakao M. ZK98299, a novel antiprogesterone does not interact with chicken oviduct progesterone receptor. Biochim. Biophys. Acta 1991; 1094: 185–192
   PubMedGoogle Scholar
• Garcia T., Benhamou B., Gofflo D., Vergezac A., Philibert D., Chambon P., Gronemeyer H. Manuscript in preparation
   Google Scholar